首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Structure-cytotoxicity relationship in a series of N-phosphorus substituted E,E-3,5-bis(3-pyridinylmethylene)- and E,E-3,5-bis(4-pyridinylmethylene)piperid-4-ones.
【24h】

Structure-cytotoxicity relationship in a series of N-phosphorus substituted E,E-3,5-bis(3-pyridinylmethylene)- and E,E-3,5-bis(4-pyridinylmethylene)piperid-4-ones.

机译:一系列N-磷取代的E,E-3,5-双(3-吡啶基亚甲基)-和E,E-3,5-双(4-吡啶基亚甲基)哌啶-4-酮的结构-细胞毒性关系。

获取原文
获取原文并翻译 | 示例
           

摘要

In order to give further insight on the influence of the aromatic ring nature and the presence of the phosphorus substituent at the piperidone nitrogen atom of E,E-3,5-bis((hetero)arylidene)piperid-4-ones on their antitumor properties, a series of phosphorus substituted E,E-3,5-bis(pyridinylmethylene)piperid-4-ones bearing either 3-pyridine or 4-pyridine rings was obtained. Novel NH-3,5-bis(pyridinylmethylene)piperid-4-ones 1a,b were converted into the corresponding N-phosphorylated derivatives 3a-c, 4a-c differing in the substitution at the phosphorus atom (amidophosphates and amidophosphonates), via direct phosphorylation while N-(omega-phosphorylalkyl)-substituted compounds 8a-c were obtained via aldol-crotonic condensation of preformed N-phosphorylalkyl substituted piperidones with the corresponding pyridinecarboxaldehyde. The cytotoxicity screen has revealed that phosphorylated compounds based on E,E-3,5-bis(4-pyridinylmethylene)piperid-4-one framework displayed higher inhibitory properties toward Caov3, A549, KB 3-1 and KB 8-5 human carcinoma cell lines comparing with their analogues with 3-pyridine rings. Introduction of the phosphorus moiety substantially increased the antitumor properties in the case of E,E-3,5-bis(3-pyridinylmethylene)piperid-4-ones derivatives but this influence less pronounced for more active analogues bearing 4-pyridinyl rings. Most of the compounds tested are potent against multi-drug resistant cell line KB 8-5 affording some guidelines for the search of perspective drug-candidates among phosphorus substituted E,E-3,5-bis((hetero)arylidene)piperid-4-ones.
机译:为了进一步了解芳族环的性质以及E,E-3,5-双((杂)亚芳基)哌啶-4-酮的哌啶酮氮​​原子上磷取代基的存在对它们的抗肿瘤性的影响的性质,得到一系列带有3-吡啶或4-吡啶环的磷取代的E,E-3,5-双(吡啶基亚甲基)哌啶-4-酮。将新的NH-3,5-双(吡啶基亚甲基)哌啶-4-酮1a,b通过以下方式转化为相应的N-磷酸化衍生物3a-c,4a-c:在磷原子上的取代不同(酰胺基磷酸酯和酰胺基膦酸酯)通过预先形成的N-磷酰基烷基取代的哌啶酮与相应的吡啶甲醛的醛醇-丁烯醛缩合反应,获得N-(ω-磷酰基烷基)-取代的化合物8a-c。细胞毒性筛选显示,基于E,E-3,5-双(4-吡啶基亚甲基)哌啶-4-酮骨架的磷酸化化合物对Caov3,A549,KB 3-1和KB 8-5人体癌表现出更高的抑制作用细胞系与其具有3-吡啶环的类似物进行比较。在E,E-3,5-双(3-吡啶基亚甲基)哌啶-4-酮衍生物的情况下,磷部分的引入实质上提高了抗肿瘤特性,但是对于带有4-吡啶基环的活性更高的类似物,这种影响不太明显。测试的大多数化合物对多药耐药细胞株KB 8-5均有效,为在磷取代的E,E-3,5-双((杂)芳基)哌啶4中寻找有前景的候选药物提供了一些指南-那些。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号